We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

95 hedge funds and large institutions have $123M invested in Cytokinetics in 2013 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 33 increasing their positions, 28 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

198% more call options, than puts

Call options by funds: $2.99M | Put options by funds: $1M

18% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 28

6% less funds holding

Funds holding: 101 → 95 (-6)

13% less capital invested

Capital invested by funds: $141M → $123M (-$17.7M)

26% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 23

Holders
95
Holders Change
-6
Holders Change %
-5.94%
% of All Funds
2.76%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
17
Increased
33
Reduced
28
Closed
23
Calls
$2.99M
Puts
$1M
Net Calls
+$1.99M
Net Calls Change
-$1.49M

Top Buyers

1
BI
BVF Inc
California
+$4.27M
2
TC
TFS Capital
Pennsylvania
+$2.99M
3
Renaissance Technologies
Renaissance Technologies
New York
+$2.2M
4
BA
BlackRock Advisors
Delaware
+$1.77M
5
Deutsche Bank
Deutsche Bank
Germany
+$983K

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$10.9M
2
BIM
Bogle Investment Management
Massachusetts
-$3.38M
3
Millennium Management
Millennium Management
New York
-$2.05M
4
Morgan Stanley
Morgan Stanley
New York
-$802K
5
GACM
Green Arrow Capital Management
New York
-$757K
Name Holding Trade Value Shares
Change 		Change in
Stake
SGAM
26
Smith Group Asset Management
Texas
$1.38M +$470K +71,547 +51%
Morgan Stanley
27
Morgan Stanley
New York
$1.11M -$802K -122,059 -42%
VAM
28
Visium Asset Management
New York
$1.09M -$12.5K -1,900 -1%
SFM
29
Sphera Funds Management
Israel
$1.09M +$1.1M +167,000 New
IHM
30
Iguana Healthcare Management
New York
$975K +$985K +150,000 New
CCI
31
Columbus Circle Investors
$910K -$337K -51,255 -27%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$866K +$4.71K +717 +0.5%
GAI
33
General American Investors
New York
$855K – – –
FLAM
34
First Light Asset Management
Minnesota
$848K +$857K +130,451 New
Jacobs Levy Equity Management
35
Jacobs Levy Equity Management
New Jersey
$822K +$540K +82,215 +186%
Geode Capital Management
36
Geode Capital Management
Massachusetts
$799K +$12K +1,833 +2%
Arrowstreet Capital
37
Arrowstreet Capital
Massachusetts
$774K -$263K -40,005 -25%
WMSA
38
Weiss Multi-Strategy Advisers
New York
$715K -$5.46K -831 -0.7%
Dimensional Fund Advisors
39
Dimensional Fund Advisors
Texas
$691K -$27.6K -4,208 -4%
American Century Companies
40
American Century Companies
Missouri
$655K -$621K -94,570 -48%
CS
41
Credit Suisse
Switzerland
$548K +$123K +18,770 +29%
BIM
42
BlackRock Investment Management
Delaware
$499K -$7.91K -1,204 -2%
Susquehanna International Group
43
Susquehanna International Group
Pennsylvania
$490K +$276K +42,055 +126%
CC
44
Curian Capital
Colorado
$415K -$4.28K -652 -1%
California Public Employees Retirement System
45
California Public Employees Retirement System
California
$378K -$6.57K -1,000 -2%
HVC
46
Healthcare Value Capital
New Jersey
$368K – – –
BCM
47
Bridgeway Capital Management
Texas
$349K – – –
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$312K +$2.63K +400 +0.8%
KeyBank National Association
49
KeyBank National Association
Ohio
$293K +$120K +18,212 +68%
TA
50
Teachers Advisors
New York
$261K +$37.1K +5,650 +16%
1
2
3 4 5

CYTK Hedge Fund Activity: Q4 2013 in Review

95 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q4 2013, worth a combined $123M — down 13% from $141M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of CYTK and 17 opened new positions — a net loss of 6 holders — while 28 trimmed existing stakes and 33 added.

The largest buyer was BVF Inc, adding an estimated $4.27M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $10.9M sold.

  • 95 institutional investors held Cytokinetics (CYTK) as of Q4 2013, down from 101 in Q3 2013.
  • Funds reported $123M of Cytokinetics stock for Q4 2013, down 13% quarter-over-quarter.
  • 17 funds opened new Cytokinetics positions in Q4 2013 and 23 closed out, a net change of -6 holders.
  • The largest Cytokinetics buyer in Q4 2013 was BVF Inc, an estimated $4.27M added.
  • The largest Cytokinetics seller in Q4 2013 was T. Rowe Price Associates, an estimated $10.9M sold.

Based on aggregated 13F filings for Q4 2013.